The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound
The German Federal Cartel Office has cleared Siemens Medical Engineering Group to proceed with completion of its offer to purchase all the outstanding shares of common stock of Acuson (SCAN, 10/11/00), the only remaining major independent ultrasound vendor, at $23 a share.
The offer, which would merge the American firm into a wholly owned subsidiary of Siemens and create the world's largest ultrasound company, remains conditional on expiration of the waiting period under U.S. antitrust law.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.